Metraipolis › archive › dc_3b06bbbab902
Artificial Intelligence in Managing Spasticity with Botulinum Toxin Type A-Insights from an Exploratory Pilot Investigation: The AIMS Study — Europe PMC PMID:41441609
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41441609
- DOI
- 10.3390/toxins17120573
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:56:56.548Z
- SHA-256 of the archived text
c53f3601bcd8ace95185d9df620f0c3cc94a405e6fd5d92e59c034247f886b79- Stable URL of this page
https://metraipolis.com/documento/dc_3b06bbbab902
How to cite
Artificial Intelligence in Managing Spasticity with Botulinum Toxin Type A-Insights from an Exploratory Pilot Investigation: The AIMS Study — Europe PMC PMID:41441609 — Europe PMC (en), https://europepmc.org/article/MED/41441609 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3b06bbbab902 (Metraipolis archive dc_3b06bbbab902, sha256 c53f3601bcd8ace95185d9df620f0c3cc94a405e6fd5d92e59c034247f886b79)
BibTeX
@misc{dc3b06bbbab902,
title = {Artificial Intelligence in Managing Spasticity with Botulinum Toxin Type A-Insights from an Exploratory Pilot Investigation: The AIMS Study — Europe PMC PMID:41441609},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41441609},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3b06bbbab902; sha256 c53f3601bcd8ace95185d9df620f0c3cc94a405e6fd5d92e59c034247f886b79},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41441609. Agents can read the archived copy with the MCP tool read_document.